Back to Search Start Over

Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: A multicenter study

Authors :
Jitao Wang
Tianlei Zheng
Yong Liao
Shi Geng
Jinlong Li
Zhanguo Zhang
Dong Shang
Chengyu Liu
Peng Yu
Yifei Huang
Chuan Liu
Yanna Liu
Shanghao Liu
Mingguang Wang
Dengxiang Liu
Hongrui Miao
Shuang Li
Biao Zhang
Anliang Huang
Yewei Zhang
Xiaolong Qi
Shubo Chen
Source :
Frontiers in Oncology, Vol 12 (2022)
Publication Year :
2022
Publisher :
Frontiers Media S.A., 2022.

Abstract

IntroductionPost-hepatectomy liver failure (PHLF) is one of the most serious complications and causes of death in patients with hepatocellular carcinoma (HCC) after hepatectomy. This study aimed to develop a novel machine learning (ML) model based on the light gradient boosting machines (LightGBM) algorithm for predicting PHLF.MethodsA total of 875 patients with HCC who underwent hepatectomy were randomized into a training cohort (n=612), a validation cohort (n=88), and a testing cohort (n=175). Shapley additive explanation (SHAP) was performed to determine the importance of individual variables. By combining these independent risk factors, an ML model for predicting PHLF was established. The area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value, negative predictive value, and decision curve analyses (DCA) were used to evaluate the accuracy of the ML model and compare it to that of other noninvasive models.ResultsThe AUCs of the ML model for predicting PHLF in the training cohort, validation cohort, and testing cohort were 0.944, 0.870, and 0.822, respectively. The ML model had a higher AUC for predicting PHLF than did other non-invasive models. The ML model for predicting PHLF was found to be more valuable than other noninvasive models.ConclusionA novel ML model for the prediction of PHLF using common clinical parameters was constructed and validated. The novel ML model performed better than did existing noninvasive models for the prediction of PHLF.

Details

Language :
English
ISSN :
2234943X
Volume :
12
Database :
Directory of Open Access Journals
Journal :
Frontiers in Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.5b98ea200ca456284baf50b66bb2f7a
Document Type :
article
Full Text :
https://doi.org/10.3389/fonc.2022.986867